At GSK we see a world in which advanced applications of Machine Learning and AI will allow us to develop transformational medicines using the power of genetics, functional genomics and machine learning. AI will also play a role in how we diagnose and use medicines to enable everyone to do more feel better and live longer. It is an ambitious vision that will require the development of products at the cutting edge of Machine Learning and AI.
 
The opportunities for machine learning extend to many other areas of our business, including medicine safety, manufacturing, and supply chain. To realize these opportunities, GSK has created a global Artificial Intelligence and Machine learning group (AI/ML), with locations in London, San Francisco, Boston, Philadelphia, Tel Aviv, and Heidelberg, to focus on the development and application of machine learning to problems of critical importance at GSK. We are now embarking on an AI/ML team in China, to bring cutting-edge solutions to real...